60.9 F
Laguna Hills
Saturday, Jun 15, 2024
-Advertisement-

Aeon Biopharma to Slash Workforce in Half

Announces reorganization; stops migraine research

Aeon Biopharma Inc. (NYSE: AEON) announced a cost reduction plan that includes stopping research on its migraine drug and cutting half of its workforce.

Shares of the Irvine-based clinical-stage biopharmaceutical firm rose 18% to $1.63 and a $64 million market cap.

Aeon terminated Peter Reynolds as chief financial officer. It appointed Chief Executive Marc Forth as principal financial officer and Controller Jennifer Sy as principal accounting officer. Before the cuts, Aeon had 10 employees.

The company said its current cash and cash equivalents will be enough to fund operations until the fourth quarter. It reported $1.6 million in cash and equivalents as of March 31.

Aeon shares fell 50% to $1.70 on May 3 after the company announced its Phase 2 trial to treat migraines failed to meet its primary endpoint. The shares had topped $16 each as recently as March.

“Following a strategic review of our resources, we made the decision to implement several cost reductions that will preserve cash while still supporting corporate activities,” Forth said in a statement. “Upon securing additional capital, we would be positioned to announce a revised clinical development strategy for our pipeline.”

Want more from the best local business newspaper in the country?

Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!

Peter J. Brennan
Peter J. Brennan
Peter J. Brennan has been a journalist for 40 years. He spent a decade in Latin America covering wars, narcotic traffickers, earthquakes, and business. His resume includes 15 years at Bloomberg News where his headlines and articles sometimes moved the market caps of companies he covered by hundreds of millions of dollars. His articles have been published worldwide, including the New York Times and the Washington Post; he's appeared on CNN, CBC, BBC, and Bloomberg TV. He was awarded a Kiplinger Fellowship at The Ohio State University.
-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-